# Alto Ingredients, Inc.: financial statements, quarterly

ALTO · Nasdaq · CIK 778164 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/alto.md) · [Financials](/companies/alto/financials.md) · [Filings](/companies/alto/filings.md) · [Insiders](/companies/alto/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/alto/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [318](/filings/0001213900-24-095907.md) | [274 d](/filings/0001213900-26-027687.md) | [241](/filings/0001213900-25-041532.md) | [236](/filings/0001213900-25-073660.md) | [252](/filings/0001213900-25-107625.md) | [236 d](/filings/0001213900-26-027687.md) | [227](/filings/0001213900-26-053870.md) | [218](/filings/0001213900-26-086336.md) | [241](/filings/0001213900-25-107625.md) | [232 d](/filings/0001213900-26-027687.md) | [225](/filings/0001213900-26-053870.md) | [246](/filings/0001213900-26-086336.md) |
| Cost of revenue | $m | [314](/filings/0001213900-24-095907.md) | [276 d](/filings/0001213900-26-027687.md) | [243](/filings/0001213900-25-041532.md) | [229](/filings/0001213900-25-073660.md) | [246](/filings/0001213900-25-107625.md) | [238 d](/filings/0001213900-26-027687.md) | [228](/filings/0001213900-26-053870.md) | [220](/filings/0001213900-26-086336.md) | [217](/filings/0001213900-25-107625.md) | [217 d](/filings/0001213900-26-027687.md) | [215](/filings/0001213900-26-053870.md) | [229](/filings/0001213900-26-086336.md) |
| Gross profit | $m | [4.2](/filings/0001213900-24-095907.md) | [(2.5) d](/filings/0001213900-26-027687.md) | [(2.4)](/filings/0001213900-25-041532.md) | [7.6](/filings/0001213900-25-073660.md) | [6.0](/filings/0001213900-25-107625.md) | [(1.4) d](/filings/0001213900-26-027687.md) | [(1.8)](/filings/0001213900-26-053870.md) | [(1.9)](/filings/0001213900-26-086336.md) | [23.5](/filings/0001213900-25-107625.md) | [15.2 d](/filings/0001213900-26-027687.md) | [9.2](/filings/0001213900-26-053870.md) | [16.6](/filings/0001213900-26-086336.md) |
| Selling, general and administrative | $m | [8.5](/filings/0001213900-24-095907.md) | [5.6 d](/filings/0001213900-26-027687.md) | [7.9](/filings/0001213900-25-041532.md) | [9.0](/filings/0001213900-25-073660.md) | [7.5](/filings/0001213900-25-107625.md) | [5.3 d](/filings/0001213900-26-027687.md) | [7.2](/filings/0001213900-26-053870.md) | [6.2](/filings/0001213900-26-086336.md) | [6.5](/filings/0001213900-25-107625.md) | [7.3 d](/filings/0001213900-26-027687.md) | [6.7](/filings/0001213900-26-053870.md) | [8.0](/filings/0001213900-26-086336.md) |
| Operating income | $m | [(4.3)](/filings/0001213900-24-095907.md) | [(17.2) d](/filings/0001213900-26-027687.md) | [(10.3)](/filings/0001213900-25-041532.md) | [(1.4)](/filings/0001213900-25-073660.md) | [(0.7)](/filings/0001213900-25-107625.md) | [(39.2) d](/filings/0001213900-26-027687.md) | [(9.0)](/filings/0001213900-26-053870.md) | [(8.1)](/filings/0001213900-26-086336.md) | [17.0](/filings/0001213900-25-107625.md) | [7.5 d](/filings/0001213900-26-027687.md) | [2.5](/filings/0001213900-26-053870.md) | [8.6](/filings/0001213900-26-086336.md) |
| Interest expense | $m | not reported | not reported | [0.9](/filings/0001213900-24-040876.md) | [1.7](/filings/0001213900-25-073660.md) | [1.9](/filings/0001213900-25-107625.md) | [2.5 d](/filings/0001213900-26-027687.md) | [2.7](/filings/0001213900-26-053870.md) | [2.8](/filings/0001213900-26-086336.md) | [2.8](/filings/0001213900-25-107625.md) | [2.4 d](/filings/0001213900-26-027687.md) | [2.2](/filings/0001213900-26-053870.md) | [2.0](/filings/0001213900-26-086336.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(3.5)](/filings/0001213900-24-095907.md) | [(18.9) d](/filings/0001213900-26-027687.md) | [(11.7)](/filings/0001213900-25-107625.md) | [(3.1)](/filings/0001213900-25-107625.md) | [(2.4)](/filings/0001213900-25-107625.md) | [(41.7) d](/filings/0001213900-26-027687.md) | [(11.7)](/filings/0001213900-26-086336.md) | [(11.0)](/filings/0001213900-26-086336.md) | [14.2](/filings/0001213900-25-107625.md) | [21.8 d](/filings/0001213900-26-027687.md) | [4.3](/filings/0001213900-26-086336.md) | [11.7](/filings/0001213900-26-086336.md) |
| Diluted EPS | $ per share | [(0.05)](/filings/0001213900-24-095907.md) | not reported | [(0.17)](/filings/0001213900-25-041532.md) | [(0.05)](/filings/0001213900-25-073660.md) | [(0.04)](/filings/0001213900-25-107625.md) | not reported | [(0.16)](/filings/0001213900-26-053870.md) | [(0.15)](/filings/0001213900-26-086336.md) | [0.19](/filings/0001213900-25-107625.md) | not reported | [0.05](/filings/0001213900-26-053870.md) | [0.15](/filings/0001213900-26-086336.md) |
| Basic EPS | $ per share | [(0.05)](/filings/0001213900-24-095907.md) | not reported | [(0.17)](/filings/0001213900-25-041532.md) | [(0.05)](/filings/0001213900-25-073660.md) | [(0.04)](/filings/0001213900-25-107625.md) | not reported | [(0.16)](/filings/0001213900-26-053870.md) | [(0.15)](/filings/0001213900-26-086336.md) | [0.19](/filings/0001213900-25-107625.md) | not reported | [0.05](/filings/0001213900-26-053870.md) | [0.15](/filings/0001213900-26-086336.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [26.2](/filings/0001213900-24-095907.md) | [30.0](/filings/0001213900-26-027687.md) | [29.3](/filings/0001213900-25-041532.md) | [27.1](/filings/0001213900-25-073660.md) | [33.6](/filings/0001213900-25-107625.md) | [35.5](/filings/0001213900-26-027687.md) | [26.8](/filings/0001213900-26-053870.md) | [29.8](/filings/0001213900-26-086336.md) | [32.5](/filings/0001213900-25-107625.md) | [23.4](/filings/0001213900-26-086336.md) | [20.3](/filings/0001213900-26-053870.md) | [24.0](/filings/0001213900-26-086336.md) |
| Current assets | $m | [168](/filings/0001213900-23-084784.md) | [169](/filings/0001213900-25-023709.md) | [151](/filings/0001213900-24-040876.md) | [154](/filings/0001213900-24-066660.md) | [145](/filings/0001213900-24-095907.md) | [153](/filings/0001213900-26-027687.md) | [153](/filings/0001213900-25-041532.md) | [150](/filings/0001213900-25-073660.md) | [151](/filings/0001213900-25-107625.md) | [156](/filings/0001213900-26-086336.md) | [159](/filings/0001213900-26-053870.md) | [161](/filings/0001213900-26-086336.md) |
| Total assets | $m | [461](/filings/0001213900-23-084784.md) | [454](/filings/0001213900-25-023709.md) | [435](/filings/0001213900-24-040876.md) | [432](/filings/0001213900-24-066660.md) | [417](/filings/0001213900-24-095907.md) | [401](/filings/0001213900-26-027687.md) | [402](/filings/0001213900-25-041532.md) | [393](/filings/0001213900-25-073660.md) | [388](/filings/0001213900-25-107625.md) | [389](/filings/0001213900-26-086336.md) | [386](/filings/0001213900-26-053870.md) | [397](/filings/0001213900-26-086336.md) |
| Current liabilities | $m | [58.4](/filings/0001213900-23-084784.md) | [65.3](/filings/0001213900-25-023709.md) | [55.1](/filings/0001213900-24-040876.md) | [49.8](/filings/0001213900-24-066660.md) | [45.1](/filings/0001213900-24-095907.md) | [57.8](/filings/0001213900-26-027687.md) | [53.1](/filings/0001213900-25-041532.md) | [42.5](/filings/0001213900-25-073660.md) | [42.4](/filings/0001213900-25-107625.md) | [59.1](/filings/0001213900-26-086336.md) | [41.7](/filings/0001213900-26-053870.md) | [50.4](/filings/0001213900-26-086336.md) |
| Total liabilities | $m | [163](/filings/0001213900-23-084784.md) | [175](/filings/0001213900-25-023709.md) | [166](/filings/0001213900-24-040876.md) | [167](/filings/0001213900-24-066660.md) | [153](/filings/0001213900-24-095907.md) | [176](/filings/0001213900-26-027687.md) | [188](/filings/0001213900-25-041532.md) | [185](/filings/0001213900-25-073660.md) | [166](/filings/0001213900-25-107625.md) | [144](/filings/0001213900-26-086336.md) | [136](/filings/0001213900-26-053870.md) | [137](/filings/0001213900-26-086336.md) |
| Long-term debt | $m | [75.9](/filings/0001213900-23-084784.md) | [82.1](/filings/0001213900-25-023709.md) | [84.1](/filings/0001213900-24-040876.md) | [91.0](/filings/0001213900-24-066660.md) | [83.3](/filings/0001213900-24-095907.md) | [92.9](/filings/0001213900-26-027687.md) | [111](/filings/0001213900-25-041532.md) | [118](/filings/0001213900-25-073660.md) | [101](/filings/0001213900-25-107625.md) | [63.0](/filings/0001213900-26-086336.md) | [73.1](/filings/0001213900-26-053870.md) | [60.5](/filings/0001213900-26-086336.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [16.6](/filings/0001213900-26-086336.md) | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [298](/filings/0001213900-24-095907.md) | [280](/filings/0001213900-26-027687.md) | [269](/filings/0001213900-25-107625.md) | [266](/filings/0001213900-25-107625.md) | [264](/filings/0001213900-25-107625.md) | [225](/filings/0001213900-26-086336.md) | [214](/filings/0001213900-26-086336.md) | [208](/filings/0001213900-26-086336.md) | [222](/filings/0001213900-25-107625.md) | [245](/filings/0001213900-26-086336.md) | [250](/filings/0001213900-26-086336.md) | [260](/filings/0001213900-26-086336.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [23.1 d](/filings/0001213900-24-095907.md) | [11.8 d](/filings/0001213900-26-027687.md) | [1.4](/filings/0001213900-25-041532.md) | [(13.7) d](/filings/0001213900-25-073660.md) | [18.6 d](/filings/0001213900-25-107625.md) | [(9.8) d](/filings/0001213900-26-027687.md) | [(18.2)](/filings/0001213900-26-053870.md) | [(0.8) d](/filings/0001213900-26-086336.md) | [22.8 d](/filings/0001213900-25-107625.md) | [9.5 d](/filings/0001213900-26-027687.md) | [4.2](/filings/0001213900-26-053870.md) | [28.5 d](/filings/0001213900-26-086336.md) |
| Capital expenditure | $m | [6.6 d](/filings/0001213900-24-095907.md) | [4.9 d](/filings/0001213900-26-027687.md) | [4.6](/filings/0001213900-25-041532.md) | [4.7 d](/filings/0001213900-25-073660.md) | [0.5 d](/filings/0001213900-25-107625.md) | [1.3 d](/filings/0001213900-26-027687.md) | [0.5](/filings/0001213900-26-053870.md) | [0.5 d](/filings/0001213900-26-086336.md) | [1.6 d](/filings/0001213900-25-107625.md) | [1.9 d](/filings/0001213900-26-027687.md) | [0.9](/filings/0001213900-26-053870.md) | [10.6 d](/filings/0001213900-26-086336.md) |
| Share repurchases | $m | [0.0 d](/filings/0001213900-24-095907.md) | [1.0 d](/filings/0001213900-26-027687.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [73.0](/filings/0001213900-23-084784.md) | [73.8](/filings/0001213900-24-040876.md) | [74.1](/filings/0001213900-24-066660.md) | [73.2](/filings/0001213900-24-095907.md) | [72.8](/filings/0001213900-25-041532.md) | [73.5](/filings/0001213900-25-073660.md) | [73.8](/filings/0001213900-25-107625.md) | [73.8](/filings/0001213900-26-053870.md) | [74.6](/filings/0001213900-26-086336.md) | [74.8](/filings/0001213900-25-107625.md) | [76.6](/filings/0001213900-26-053870.md) | [77.1](/filings/0001213900-26-086336.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 77,567,564 at 2026-08-06, from the cover of the [10-Q filed 2026-08-07](/filings/0001213900-26-086336.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.